TherapeuticsMD (TXMD) Non-cash Items (2021 - 2026)

TherapeuticsMD's Non-cash Items history runs 6 years deep, the most recent figure standing at $841000.0 for Q1 2026.

• Quarterly Non-cash Items fell 37.0% year-over-year to $841000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 38.33% YoY) and the FY2025 annual result came in at $3.1 million, down 10.77% from the prior year.
• Non-cash Items was $841000.0 for Q1 2026 at TherapeuticsMD, down from $987000.0 in the prior quarter.
• Across five years, Non-cash Items topped out at $32.3 million in Q3 2022 and bottomed at -$18.2 million in Q4 2022.
• A 5-year average of $19588.2 and a median of $3000.0 in 2022 frame the typical range for Non-cash Items.
• Annual changes were most pronounced in 2023 — Non-cash Items tumbled 213133.33% — and 2025, when it jumped 1117.53%.
• TherapeuticsMD's Non-cash Items stood at -$18.2 million in 2022, then soared by 81.23% to -$3.4 million in 2023, then jumped by 97.16% to -$97000.0 in 2024, then soared by 1117.53% to $987000.0 in 2025, then declined by 14.79% to $841000.0 in 2026.
• Business Quant data shows TXMD's Non-cash Items at $841000.0 in Q1 2026, $987000.0 in Q4 2025, and $949000.0 in Q3 2025.